Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan W Johnson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Genes & Development|February 26, 2003
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressorKaren Cichowski, Sabrina Santiago, Melanie Jardim, et al.
Cancer Cell|December 13, 2006
A negative feedback signaling network underlies oncogene-induced senescenceStéphanie Courtois-Cox, Sybil M Genther Williams, Elizabeth E Reczek, et al.
Current Biology : CB|January 1, 2008
TORC1 is essential for NF1-associated malignanciesCory M Johannessen, Bryan W Johnson, Sybil M Genther Williams, et al.
Molecular Cancer Therapeutics|November 28, 2013
MM-141, an IGF-IR- and ErbB3-directed bispecific antibody, overcomes network adaptations that limit activity of IGF-IR inhibitorsJonathan B Fitzgerald, Bryan W Johnson, Jason Baum, et al.
Cancer Cell|July 4, 2009
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesisLauren T McGillicuddy, Jody A Fromm, Pablo E Hollstein, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Genes & Development|February 26, 2003
Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressorKaren Cichowski, Sabrina Santiago, Melanie Jardim, et al.
Cancer Cell|December 13, 2006
A negative feedback signaling network underlies oncogene-induced senescenceStéphanie Courtois-Cox, Sybil M Genther Williams, Elizabeth E Reczek, et al.
Current Biology : CB|January 1, 2008
TORC1 is essential for NF1-associated malignanciesCory M Johannessen, Bryan W Johnson, Sybil M Genther Williams, et al.
Molecular Cancer Therapeutics|November 28, 2013
MM-141, an IGF-IR- and ErbB3-directed bispecific antibody, overcomes network adaptations that limit activity of IGF-IR inhibitorsJonathan B Fitzgerald, Bryan W Johnson, Jason Baum, et al.
Cancer Cell|July 4, 2009
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesisLauren T McGillicuddy, Jody A Fromm, Pablo E Hollstein, et al.
Pageof 1